Compare TRNR & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRNR | ACON |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5M | 3.0M |
| IPO Year | 2023 | 2022 |
| Metric | TRNR | ACON |
|---|---|---|
| Price | $0.39 | $2.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | ★ 2.8M | 141.3K |
| Earning Date | 03-30-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,774,000.00 | $67,483.00 |
| Revenue This Year | $245.67 | $71.77 |
| Revenue Next Year | $308.85 | $80.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 207.36 | 36.91 |
| 52 Week Low | $0.30 | $2.34 |
| 52 Week High | $39.60 | $229.50 |
| Indicator | TRNR | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 26.71 | 32.75 |
| Support Level | $0.30 | $2.50 |
| Resistance Level | $0.41 | $2.85 |
| Average True Range (ATR) | 0.07 | 0.24 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 15.09 | 17.60 |
Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue and personal training revenue.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.